Wang Y, Shan X, Liang Z, Shan Y, Huang W, Zhang D, Zen A, Zhou X, Zhao Y, Gong X, Xu G, Zhang X, Chen J, Huang A. Deep sequencing analysis of HBV genotype shift and correlation with antiviral efficiency during adefovir dipivoxil therapy.PloS one.2015,10 (6), e0131337.

Fu Q, Tang X, Chen J, Su L, Zhang M, Wang L, Jing J, Zhou L. Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population. PLoS One. 2015,Sep 23;10(9):e0138652.

Wang YW, Shan X, Huang Y, Deng H, Huang WX, Zhang D, Chen J, Tang N, Shan YL, Guo JJ, Huang A. A novel baseline hepatitis B virus sequencing-based strategy for predicting adefovir antiviral response. Infect Genet Evol. 2015, Jul;33:269-76.

Huang Y, Deng H, Shan X, Gong X, Li X, Tu Z, Long Q, Huang A. Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patients. PLoS One.2015,Mar 30;10(3):e0120733.

Cao Y, Zhang J, Xiong D, Wang D, Wu T, Huang A, Tang H. Hsa-miR-331-3p inhibits VHL expression by directly targeting its mRNA 3'-UTR in HCC cell lines. Acta Biochim Pol.2015,62(1):77-82. Epub 2015 Feb 26.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Oncotarget. 2015,Nov 10;6(35):38093-106.

Shan X, Ren M, Chen K, Huang A, Tang H. Regulation of the microRNA processor DGCR8 by hepatitis B virus proteins via the transcription factor YY1. Arch Virol. 2015,Mar;160(3):795-803.

Zou C, Chen J, Chen K, Wang S, Cao Y, Zhang J, Sheng Y, Huang A, Tang H. Functional analysis of miR-181a and Fas involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis.Exp Cell Res.2015,Feb 15;331(2):352- 61.

Li X, Zhu J, Lai G, Yan L, Hu J, Chen J, Tang N, Huang A. The infection efficiency and replication ability of circularized HBV DNA optimized the linear HBV DNA in vitro and in vivo. Int J Mol Sci.2015, Mar 5;16(3):5141-60.

Long X, Gou Y, Luo M, Zhang S, Zhang H, Bai L, Wu S, He Q, Chen K, Huang A, Zhou , Wang D. Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli. BMC Biotechnol.2015,Mar 1;15:13.

Zhao L, Zhong S, Qu H, Xie Y, Cao Z, Li Q, Yang P, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Chronic inflammation aggravates metabolic disorders of hepatic fatty acids in high-fat diet-induced obese mice. Sci Rep.2015, May 14;5:10222.

Yang P, Zhao Y, Zhao L, Yuan J, Chen Y, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo. Sci Rep. 2015 Oct 9;5:14959.

Zhong S, Zhao L, Li Q, Yang P, Varghese Z, Moorhead JF, Chen Y, Ruan XZ. Inflammatory Stress Exacerbated Mesangial Foam Cell Formation and Renal Injury via Disrupting Cellular Cholesterol Homeostasis. Inflammation. 2015; 38(3):959-71.

Peng H, Wei F, Liu JY, Hu HD, Ren H, Hu P. Response-guided therapy of regimens based on PEG-interferon for chronic hepatitis B using on-treatment hepatitis B surface antigen quantification: a meta-analysis. Hepatol Int.2015, 9: 543-557.

Chen M, Hu P, Ling N, Peng H, Lei Y, Hu H, Zhang D, Ren H. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro. PLoS One. 2015 Mar 16;10(3):e0120086.

Chen Y, Wu G, Zhang H, Xu H, Li H, Chen L, Yang Y, Hu P, Zhang D, Ren H, Hu H. Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis. Gastroenterol Res Pract. 2015,206302.

Liu JY, Sheng YJ, Ding XC, Tang H, Tong SW, Zhang DZ, Zhou Z, Hu P, Liao Y, Ren H, Hu HD. The efficacy of lamivudine prophylaxis against hepatitis B reactivation in breast cancer patients undergoing chemotherapy: a meta-analysis. J Formos Med Assoc.2015,114: 164-173.

Ran X, Xu X, Yang Y, She S, Yang M, Li S, Peng H, Ding X, Hu H, Hu P, Zhang D, Ren H, Wu L, Zeng W. A quantitative proteomics study on olfactomedin 4 in the development of gastric cancer. Int J Oncol.2015,47: 1932-1944.

She S, Xiang Y, Yang M, Ding X, Liu X, Ma L, Liu Q, Liu B, Lu Z, Li S, Liu Y, Ran X, Xu X, Hu H, Hu P, Zhang D, Ren H, Yang Y. C-reactive protein is a biomarker of AFP-negative HBV-related hepatocellular carcinoma. Int J Oncol.2015, 47: 543-554.

Wu CX，He LX，Guo H，Tian XX，Liu Q，Sun H. Inhibition effect of glycyrrhizin in lipopolysaccharide-induced high-mobility group box1 releasing and expression from RAW264.7 cells. Shock.2015, 43(4)：412-421.

Mu D, Yan L, Tang H, Liao Yong. A sensitive and accurate quantification method for the detection of hepatitis B virus covalently closed circular DNA by the application of a droplet digital polymerase chain reaction amplification system. Biotechnol Lett.2015,37:2063-2073.

Jiang X, Deng K.Q., Luo Y.X., Jiang D.S., Gao L., Zhang X.F., Zhang P., Zhao G.N., Zhu X.Y., Li H.L. Tumor Necrosis Factor Receptor–Associated Factor 3 Is a Positive Regulator of Pathological Cardiac Hypertrophy. Hypertension. 2015,66:356-367.

Hui Tang, Zhen Zhang, Zheng-Ke Li, Jia Lin, Ding-Zhi Fang. Association of Leptin Receptor Gene Polymorphisms with Genetic Susceptibility to Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 2015,24(9):2128-2133.

Keyue Ding, Songfeng Wu, Wantao Ying, Qi Pan, Xiaoyuan Li, Dachun Zhao, Xianyu Li, Qing Zhao, Yunping Zhu, Hong Ren & Xiaohong Qian. Leveraging a Multi-Omics Strategy for Prioritizing Personalized Candidate Mutation-Driver Genes: A Proof-of-Concept Study. Sci Rep. 2015 Dec 3;5:17564.

Xiaoyuan Li, Juan Kang, Qi Pan, Weronika Sikora-Wohlfeld, Dachun Zhao,Changting Meng,Chunmei Bai, Anil Patwardhan, Richard Chen,  Hong Ren, Atul J. Butte and Keyue Ding. Genetic analysis in a patient with nine primary malignant neoplasms: A rare case of Li-Fraumeni syndrome. Oncol Rep. 2015 Dec 21. doi: 10.3892/or.2015.4501.

Qian Feng, Yugang Chi, Yanqian Liu, Ling Zhang, Qi Liu. Efficacy and safety of percutaneous radiofrequency ablation versus surgical resection for small hepatocellular carcinoma: a meta-analysis of 23 studies. J Cancer Res Clin Oncol. 2015,141:1-9.

Yan R, Zhang L, Xia N, Liu Q, Sun H, Guo H. Knockdown of augmenter of liver regeneration in HK-2 cells inhibits inflammation response via the mitogen-activated protein kinase signaling pathway. 2015,64(6):453-62.

Yan R, Li Y, Zhang L, Xia N, Liu Q, Sun H, Guo H. Augmenter of liver regeneration attenuates inflammation of renal ischemia/ reperfusion injury through the NF-kappa B pathway in rats. Int Urol Nephrol. 2015,47(5): 861-8.

Xia N, Yan RY, Liu Q, Liao XH, Sun H, Guo H, Zhang L. Augmenter of liver regeneration plays a protective role against hydrogen peroxide-induced oxidative stress in renal proximal tubule cells. Apoptosis. 2015,20(4): 423-32.

Liu F, Zou F, Wang X, Hu H, Hu P, Ren H. A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study. Virol J. 2015, 12: 179.

Liu F, Wang X, Wu G, Chen L, Hu P, Ren H, Hu H.Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis. PLoS One. 2015, 10(11): e0142457.

Xiang Y, Liu Y, Yang Y, Hu H, Hu P, Ren H, Zhang D.A secretomic study on human hepatocellular carcinoma multiple drug-resistant cell lines. Oncol Rep. 2015, 34(3): 1249-60.